Skip to content

Net margin at other companies

Kymera Therapeutics logo
Kymera TherapeuticsKYMR
-612%+602pp
Monte Rosa Therapeutics, Inc. logo
Monte Rosa Therapeutics, Inc.GLUE
-302.6%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
-529.2%-556pp
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
-508.5%-254pp
Nuvation Bio logo
Nuvation BioNUVB
-102.1%-50.6pp
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-90.9%-2.1pp

Other financials

Income statement

See full
Revenue$6.3M-66.1%
Operating income-$92.5M-47.1%
Net income-$87.2M-54.7%
EPS (diluted)-$0.79-17.9%

Balance sheet

See full
Cash & equivalents$72.2M-6.1%
Total debt$58.7M+120%
Total equity$480.9M0.0%
Total assets$636.1M+3.4%

Cash flow

See full
Operating cash flow-$71.9M-17.7%
CapEx$1.0M-70.0%
Free cash flow-$73.0M-13.0%

Valuation

See full
Market cap$1.95B+40.1%
Enterprise value$1.94B+45.1%
P/S27.2×+2.5×

Profitability

See full
Operating margin-439.3%+35.3pp
FCF margin-378.7%+24.1pp

Returns & leverage

See full
Return on equity-61.4%-2.5pp
Debt / equity0.1×+0.1×
Current ratio-0.3×

Where this comes from

Calculated from Nurix Therapeutics, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nurix Therapeutics, Inc.'s net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nurix Therapeutics, Inc.'s net margin?
Nurix Therapeutics, Inc. (NRIX) reported net margin of -411.4% in Q4 2025.
How has Nurix Therapeutics, Inc.'s net margin changed year-over-year?
Nurix Therapeutics, Inc.'s net margin decreased by 11.4% year-over-year, from -369.4% to -411.4%.
What is the long-term trend for Nurix Therapeutics, Inc.'s net margin?
Over 5 years (2020 to 2025), Nurix Therapeutics, Inc.'s net margin has grown at a 5.4% compound annual growth rate (CAGR), from -242.7% to -314.9%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.